RxDoctor Payments Data
★ My doctorsLook up a doctor →

T Singh

Hematology & Oncology · Flint, MINPI 1396726931

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 362 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 56 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,314 and has fallen 99.5% since, to $17 in 2023.

$8,706in general payments, 2019–2025

Across 362 payments — averaging $24.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Johnson & Johnson$884
  • Genentech USA, Inc.$577
  • Amgen$379
  • Merck$356
  • Takeda Pharmaceuticals U.S.A., Inc.$342
  • plus $5K from 50 others

What the payments were for

  • Consulting fees$1001%
  • Speaking & faculty fees$350%
  • Food & beverage$8,11893%
  • Education$4535%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)32$1,155
Johnson & Johnson(2 entities)32$884
Genentech USA, Inc.29$577
Amgen20$379
Merck16$356
Takeda Pharmaceuticals U.S.A., Inc.13$342
Sanofi13$334
E.r. Squibb & Sons, L.L.C.13$331
Eisai Inc.8$284
Pfizer22$247
GSK7$212
Lilly USA, LLC11$205
Bayer7$203
G1 Therapeutics, Inc.2$191
Beigene USA, Inc.6$190
Bristol Myers Squibb8$189
Abbott1$181
Karyopharm Therapeutics Inc.5$176
Exelixis Inc.6$166
Tesaro, Inc.4$133
Seagen Inc.9$131
Dova Pharmaceuticals3$127
EMD Serono, Inc.5$121
Novartis7$119
Jazz Pharmaceuticals Inc.6$118
Gilead(2 entities)8$116
Incyte Corporation7$105
Coherus Oncology, Inc.2$82
Ipsen Biopharmaceuticals, Inc4$80
AbbVie4$73
Epizyme, Inc.3$64
Agios Pharmaceuticals, Inc.3$60
Daiichi Sankyo Inc.2$59
Boehringer Ingelheim3$58
Rigel Pharmaceuticals, Inc.3$56
AMAG Pharmaceuticals, Inc.3$55
Clovis Oncology, Inc.4$53
Mylan Institutional Inc.3$53
Puma Biotechnology, Inc.3$47
Pharmacyclics LLC, An Abbvie Company3$42
Tersera Therapeutics LLC3$41
Taiho Oncology, Inc.2$40
Blueprint Medicines Corporation2$35
Innate Pharma, Inc1$29
Regeneron Healthcare Solutions, Inc.1$28
Astellas Pharma US Inc2$27
Kyowa Kirin, Inc.2$26
Stryker1$17
Spectrum Pharmaceuticals Inc.1$17
Foundation Medicine, Inc.1$15
Deciphera Pharmaceuticals Inc.1$15
CSL Behring1$15
Helsinn Therapeutics (U.S.), Inc.1$13
Immunomedics, Inc.1$13
Array Biopharma Inc1$12
Global Blood Therapeutics, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,706 in reported general payments places this provider in the 80th percentile of 282 hematology & oncology providers in Michigan.

See all hematology & oncology providers in Michigan →

Other hematology & oncology in Flint

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →